EU/3/20/2249

Table of contents

About

On 28 February 2020, orphan designation EU/3/20/2249 was granted by the European Commission to SparingVision, France, for adeno-associated virus serotype 8 containing the human RdCVF sequence and the human RdCVFL sequence (also known as SPVN06) for the treatment of inherited retinal dystrophies.

Key facts

Active substance
Adeno-associated virus serotype 8 containing the human RdCVF sequence and the human RdCVFL sequence
Disease / condition
Treatment of inherited retinal dystrophies
Date of first decision
28/02/2020
Outcome
Positive
EU designation number
EU/3/20/2249

Sponsor's contact details

SparingVision
55 Rue De Lyon
75012 Paris
France
Tel: +33 143 462 060
E-mail: sophie.skorupka@sparingvision.com

 

Patients' organisations

For contact details of patients’ organisations whose activities are targeted at rare diseases, see:

  • European Organisation for Rare Diseases (EURORDIS), a non-governmental alliance of patient organisations and individuals active in the field of rare diseases.

  • Orphanet, a database containing information on rare diseases, which includes a directory of patients’ organisations registered in Europe.

How useful was this page?

Add your rating